Rocket Lab Faces Neutron Rocket Delay Amid Industry Headwinds

Rocket Lab USA US7731221062

Rocket Lab USA is navigating a complex set of operational and market challenges. A structural issue discovered during testing has pushed back the timeline for its next-generation Neutron rocket, compounding pressures from broader industry dynamics, including the potential for a major competitor's stock market debut to redirect investor capital.

A recent qualification test for the Neutron rocket's first stage has resulted in a schedule revision. During a hydrostatic pressure test, a tank experienced a failure. Company engineers are currently analyzing the test data to determine the full scope of the incident's implications.

As a direct consequence, the inaugural launch of the Neutron vehicle, previously targeted for 2026, has been officially postponed to late in that year. This delay represents a temporary setback for Rocket Lab's strategic aim to capture a share of the medium-lift launch market.

External Pressures: SpaceX IPO and NASA Budget Cut

The company's stock is also contending with sector-wide sentiment. Market participants anticipate a SpaceX initial public offering (IPO) around summer 2026, an event analysts believe could attract significant investment flows. This has raised concerns that publicly traded smaller peers like Rocket Lab may be overshadowed.

Further industry news adds to the context: the US Congress recently eliminated funding for the 2031 Mars Sample Return mission. This decision removes a multi-billion dollar contract opportunity for which Rocket Lab could have potentially competed.

Underlying Business Performance Remains Strong

Despite these headwinds, Rocket Lab's core operations demonstrate continued strength. In its most recent quarterly report, the company posted revenue of $155.08 million, a 48% year-over-year increase. Its backlog stands at over $500 million, indicating sustained demand for its existing Electron launch services and space systems.

Analyst sentiment reflects the current mixed outlook. On February 12, 2026, Zacks Research downgraded the equity from a "Strong Buy" to a "Hold" rating. The current consensus among analysts remains a "Moderate Buy," with average price targets ranging between approximately $66 and $73 per share.

In a separate corporate action, CEO Peter Beck recently sold shares under a pre-arranged 10b5-1 trading plan. Such plans are typically established for personal financial management and are not generally interpreted as a signal regarding near-term business prospects.

Strategic Importance of the Neutron Program

The delay for the Neutron rocket occurs at a critical juncture. The vehicle is designed to enable Rocket Lab to address more lucrative, heavier payload contracts and reduce its reliance on the smaller Electron launch system. Whether this setback is a short-term technical obstacle or a more protracted development issue will become clearer in the coming months.

@ boerse-global.de | US7731221062 ROCKET